Open access
Nov 2026
A deep-learning model based on histological images predicts survival and pathological response to neoadjuvant chemotherapy and chemoimmunotherapy in breast cancer
Accurate biomarkers for prognosis and selection of patients most likely to benefit from neoadjuvant chemoimmunotherapy in early breast cancer (eBC) are urgently needed. The Immune Constant of Rejection (ICR) gene expression signature, a 20-gene signature reflecting cytotoxic immune activation, is associated with...
F. Bertucci, Gwenael Lumet, Mathieu Delattre et al.
· Journal of Translational Med... · 0 citations